Sort   by:  
 Page size 
UnknownMechanisms of acquired resistance to first- and second-generation EGFR tyrosine kinase inhibitors.
Not available
S-EPMC6454547 | biostudies-literature
UnknownDigital quantitative assessment of PD-L1 using digital spatial profiling.
Not available
S-EPMC7502436 | biostudies-literature
UnknownQuantitative analysis of CMTM6 expression in tumor microenvironment in metastatic melanoma and association with outcome on immunotherapy.
Not available
S-EPMC7781756 | biostudies-literature
UnknownPD-1/PD-L1 Inhibitors as Monotherapy in the First-Line Treatment of Advanced Non-Small Cell Lung Cancer Patients with High PD-L1 Expression: An Expert Position Statement.
Not available
S-EPMC10420126 | biostudies-literature
UnknownProgrammed Death-Ligand 1 Tumor Proportion Score and Overall Survival From First-Line Pembrolizumab in Patients With Nonsquamous Versus Squamous NSCLC.
Not available
S-EPMC8612948 | biostudies-literature
UnknownFuture Perspectives in the Second Line Therapeutic Setting for Non-Oncogene Addicted Non-Small-Cell Lung Cancer.
Not available
S-EPMC10705719 | biostudies-literature
UnknownImmune Cell PD-L1 Colocalizes with Macrophages and Is Associated with Outcome in PD-1 Pathway Blockade Therapy.
Not available
S-EPMC7024671 | biostudies-literature
UnknownBiomarkers Associated with Beneficial PD-1 Checkpoint Blockade in Non-Small Cell Lung Cancer (NSCLC) Identified Using High-Plex Digital Spatial Profiling.
Not available
S-EPMC7442721 | biostudies-literature
UnknownMultiplex Quantitative Analysis of Tumor-Infiltrating Lymphocytes, Cancer-Associated Fibroblasts, and CD200 in Pancreatic Cancer.
Not available
S-EPMC8583434 | biostudies-literature
UnknownImmune Checkpoint Inhibitor-Associated Pericarditis.
Not available
S-EPMC6617516 | biostudies-literature
Sort   by:  
 Page size